2018
DOI: 10.3389/fimmu.2018.02424
|View full text |Cite
|
Sign up to set email alerts
|

The Role of CD1d and MR1 Restricted T Cells in the Liver

Abstract: The liver is one of the most important immunological organs that remains tolerogenic in homeostasis yet promotes rapid responses to pathogens in the presence of a systemic infection. The composition of leucocytes in the liver is highly distinct from that of the blood and other lymphoid organs, particularly with respect to enrichment of innate T cells, i.e., invariant NKT cells (iNKT cells) and Mucosal-Associated Invariant T cells (MAIT cells). In recent years, studies have revealed insights into their biology … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 129 publications
1
12
0
Order By: Relevance
“…Conventionally, liver accumulation of drug-loaded nanoparticles is strongly unwanted, and it is unanimously recognized as the major barrier to clinical translation of nanomaterials. However, in this study, liver accumulation could be desirable, given that our strategy involves the delivery of two distinct immune agents, α-GalCer and an mRNA coding for a selected tumor antigen, that are recognized by iNKT (most abundant in the liver) and T cells (most abundant in lymphoid organs), respectively . Bioluminescence distribution revealed efficient dual targeting of the liver and lymphoid organs (mostly spleen, ILNs, and MLNs) and excluded any undesired off-target signal.…”
Section: Resultsmentioning
confidence: 99%
“…Conventionally, liver accumulation of drug-loaded nanoparticles is strongly unwanted, and it is unanimously recognized as the major barrier to clinical translation of nanomaterials. However, in this study, liver accumulation could be desirable, given that our strategy involves the delivery of two distinct immune agents, α-GalCer and an mRNA coding for a selected tumor antigen, that are recognized by iNKT (most abundant in the liver) and T cells (most abundant in lymphoid organs), respectively . Bioluminescence distribution revealed efficient dual targeting of the liver and lymphoid organs (mostly spleen, ILNs, and MLNs) and excluded any undesired off-target signal.…”
Section: Resultsmentioning
confidence: 99%
“…While MR1 has been consistently found to localize to the ER, it has also been reported to co-localize with late endosomal proteins ( 30 , 36 , 37 ). We have observed a vesicular distribution of MR1 even in the absence of exogenously provided ligands ( 36 ), indicating that constitutive egress from the ER is possible.…”
Section: Distinct and Complementary Mr1 Antigen Presentation Pathwaysmentioning
confidence: 99%
“…The nature of the antigens that would stimulate iNKT cells is complex. In fact, mouse and human iNKT cells can recognize lipid and glycolipid antigens of self or microbial origin presented on MHC class-I-like CD1d molecules [ 48 , 49 ]. In this sense, intestinal permeability appears to be increased in NAFLD patients, which would allow a constant exposure to dietary and microbial antigens.…”
Section: Discussionmentioning
confidence: 99%